{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:28:52Z","timestamp":1789414132371,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.mehy.2013.01.018","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T18:32:57Z","timestamp":1360607577000},"page":"558-563","source":"Crossref","is-referenced-by-count":16,"title":["Elevated norepinephrine may be an etiological factor in a wide range of diseases: Age-related macular degeneration, systemic lupus erythematosus, atrial fibrillation, metabolic syndrome"],"prefix":"10.1016","volume":"80","author":[{"given":"Paul J.","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2013.01.018_b0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.clpt.6100355","article-title":"Metabolic syndrome: from global epidemiology to individualized medicine","volume":"82","author":"Batsis","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.mehy.2013.01.018_b0010","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.2337\/diabetes.54.12.3371","article-title":"A polygenic model of the metabolic syndrome with reduced circulating and intra-adipose glucocorticoid action","volume":"54","author":"Morton","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2013.01.018_b0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ijc.24063","article-title":"Is norepinephrine an etiological factor in some types of cancer?","volume":"124","author":"Fitzgerald","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.mehy.2013.01.018_b0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/1529-0131(200102)44:2<397::AID-ANR59>3.0.CO;2-N","article-title":"Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients","volume":"44","author":"Deng","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2013.01.018_b0025","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/archpsyc.1981.01780360103012","article-title":"Plasma MHPG in rapid cyclers and healthy twins","volume":"38","author":"Jimerson","year":"1981","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2013.01.018_b0030","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/ajh\/3.11.823","article-title":"Elevated insulin, norepinephrine, and neuropeptide Y in hypertension","volume":"3","author":"Solt","year":"1990","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mehy.2013.01.018_b0035","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1161\/CIRCULATIONAHA.104.519652","article-title":"Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5years","volume":"111","author":"Masuo","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2013.01.018_b0040","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ophtha.2003.10.024","article-title":"Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from three continents","volume":"111","author":"van Leeuwen","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mehy.2013.01.018_b0045","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3126\/kumj.v6i3.1724","article-title":"Secrets of omega-3 oil","volume":"6","author":"Suvarna","year":"2008","journal-title":"Kathmandu Univ Med J"},{"key":"10.1016\/j.mehy.2013.01.018_b0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biopha.2006.09.015","article-title":"Dietary omega-3 fatty acids for women","volume":"61","author":"Bourre","year":"2007","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.mehy.2013.01.018_b0055","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ophtha.2006.07.045","article-title":"Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans","volume":"114","author":"Duan","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mehy.2013.01.018_b0060","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ophtha.2006.09.033","article-title":"Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study","volume":"114","author":"Tan","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mehy.2013.01.018_b0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ajo.2007.10.007","article-title":"Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study","volume":"145","author":"Fraser-Bell","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.mehy.2013.01.018_b0070","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/bjo.2009.159723","article-title":"Associated factors for age-related maculopathy in the adult population in southern India: the Andhra Pradesh Eye Disease Study","volume":"93","author":"Krishnaiah","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.mehy.2013.01.018_b0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.118.3.351","article-title":"Hypertension, cardiovascular disease, and age-related macular degeneration. Age-related macular degeneration risk factors study group","volume":"118","author":"Hyman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.mehy.2013.01.018_b0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archopht.116.5.583","article-title":"Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study","volume":"116","author":"Smith","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.mehy.2013.01.018_b0085","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/archopht.119.9.1259","article-title":"Body mass index and the incidence of visually significant age-related maculopathy in men","volume":"119","author":"Schaumberg","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.mehy.2013.01.018_b0090","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/bjo.2005.066241","article-title":"A study of the relation between body mass index and the incidence of age related macular degeneration","volume":"89","author":"Moeini","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.mehy.2013.01.018_b0095","first-page":"91","article-title":"Increased chromogranin A levels indicate sympathetic hyperactivity in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"35","author":"Capellino","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.mehy.2013.01.018_b0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0090-4295(93)90592-X","article-title":"Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome","volume":"41","author":"Sandler","year":"1993","journal-title":"Urology"},{"key":"10.1016\/j.mehy.2013.01.018_b0105","first-page":"147","article-title":"A lupus erythematosus syndrome induced by clonidine hydrochloride","volume":"64","author":"Witman","year":"1981","journal-title":"R I Med J"},{"key":"10.1016\/j.mehy.2013.01.018_b0110","first-page":"48","article-title":"Psychiatric disorders in systemic lupus erythematosus","volume":"45","author":"Hutchinson","year":"1996","journal-title":"West Indian Med J"},{"key":"10.1016\/j.mehy.2013.01.018_b0115","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.58.8.1214","article-title":"Neuropsychiatric syndromes in lupus: prevalence using standardized definitions","volume":"58","author":"Brey","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2013.01.018_b0120","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.24519","article-title":"Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus","volume":"61","author":"Bachen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2013.01.018_b0125","first-page":"1092","article-title":"Autonomic dysfunction in patients with systemic lupus erythematosus","volume":"25","author":"Gamez-Nava","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.mehy.2013.01.018_b0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/01.WNL.0000149640.78684.EA","article-title":"Predictors of cognitive dysfunction in patients with systemic lupus erythematosus","volume":"64","author":"McLaurin","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2013.01.018_b0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/RHU.0b013e318124a8af","article-title":"Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico","volume":"13","author":"Molina","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.mehy.2013.01.018_b0140","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/art.21400","article-title":"Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus","volume":"52","author":"Oeser","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2013.01.018_b0145","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/RHU.0b013e31816b2faa","article-title":"Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"14","author":"Zonana-Nacach","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.mehy.2013.01.018_b0150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF01857920","article-title":"Stress, depression, and anxiety predict average symptom severity and daily symptom fluctuation in systemic lupus erythematosus","volume":"17","author":"Adams","year":"1994","journal-title":"J Behav Med"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2013.01.018_b0155","first-page":"21","article-title":"Modulation of the immune response to stress in patients with systemic lupus erythematosus: review of recent studies","volume":"22","author":"Hinrichsen","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.mehy.2013.01.018_b0160","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/brbi.1999.0553","article-title":"Patients with systemic lupus erythematosus differ from healthy controls in their immunological response to acute psychological stress","volume":"13","author":"Pawlak","year":"1999","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.mehy.2013.01.018_b0165","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/rheumatology\/40.8.868","article-title":"Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure","volume":"40","author":"Jacobs","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.mehy.2013.01.018_b0170","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/rheumatology\/41.2.184","article-title":"Psychological distress and changes in the activity of systemic lupus erythematosus","volume":"41","author":"Ward","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.mehy.2013.01.018_b0175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00210-009-0474-0","article-title":"Cardiac adrenergic control and atrial fibrillation","volume":"381","author":"Workman","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.mehy.2013.01.018_b0180","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0002-8703(99)70484-9","article-title":"Sotalol: an important new antiarrhythmic","volume":"137","author":"Anderson","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.mehy.2013.01.018_b0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jacc.2011.08.061","article-title":"A common \u03b21-adrenergic receptor polymorphism predicts favorable response to rate-control therapy in atrial fibrillation","volume":"59","author":"Parvez","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2013.01.018_b0190","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1067\/mhj.2001.116761","article-title":"Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial","volume":"142","author":"Simpson","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.mehy.2013.01.018_b0195","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1445-5994.1999.tb01588.x","article-title":"Atrial fibrillation: prevalence and management in an acute general medical unit","volume":"29","author":"Stewart","year":"1999","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.mehy.2013.01.018_b0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0828-282X(06)70265-3","article-title":"Stroke prevention in patients with atrial fibrillation: the diagnosis and management of hypertension by specialists","volume":"22","author":"Healey","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.mehy.2013.01.018_b0205","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mehy.2013.01.018_b0210","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1540-8167.2008.01118.x","article-title":"Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation","volume":"19","author":"Jongnarangsin","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.mehy.2013.01.018_b0215","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2010.02.029","article-title":"The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women\u2019s health study)","volume":"55","author":"Tedrow","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2013.01.018_b0220","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.amjmed.2009.11.026","article-title":"Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox","volume":"123","author":"Badheka","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.mehy.2013.01.018_b0225","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1365-2796.2001.00902.x","article-title":"Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors","volume":"250","author":"Wilhelmsen","year":"2001","journal-title":"J Intern Med"},{"key":"10.1016\/j.mehy.2013.01.018_b0230","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/01.psy.0000174050.87193.96","article-title":"Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study","volume":"67","author":"Eaker","year":"2005","journal-title":"Psychosom Med"},{"key":"10.1016\/j.mehy.2013.01.018_b0235","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/0003-4975(95)00718-0","article-title":"Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation","volume":"60","author":"Kalman","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.mehy.2013.01.018_b0240","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0195-668X(03)00393-2","article-title":"Chronic atrial fibrillation does not influence the magnitude of sympathetic overactivity in patients with heart failure","volume":"24","author":"Gould","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2013.01.018_b0245","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1540-8159.2006.00447.x","article-title":"Evidence for increased atrial sympathetic innervation in persistent human atrial fibrillation","volume":"29","author":"Gould","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.mehy.2013.01.018_b0250","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/HJH.0b013e328048d004","article-title":"The sympathetic nervous system and the metabolic syndrome","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.mehy.2013.01.018_b0255","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0306-9877(95)90139-6","article-title":"Excess catecholamines and the metabolic syndrome: should central imidazoline receptors be a therapeutic target?","volume":"44","author":"Rupp","year":"1995","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2013.01.018_b0260","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.numecd.2007.01.004","article-title":"Cardiovascular risk and adrenergic overdrive in the metabolic syndrome","volume":"17","author":"Grassi","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.mehy.2013.01.018_b0265","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0447.2010.01565.x","article-title":"Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use","volume":"122","author":"van Reedt Dortland","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.mehy.2013.01.018_b0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00019501-200502000-00012","article-title":"The vascular effects of doxazosin in hypertension complicated by metabolic syndrome","volume":"16","author":"Dell\u2019Omo","year":"2005","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.mehy.2013.01.018_b0275","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/157339910791658844","article-title":"Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review","volume":"6","author":"Carella","year":"2010","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.mehy.2013.01.018_b0280","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00004872-199604000-00012","article-title":"Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study","volume":"14","author":"Jacob","year":"1996","journal-title":"J Hypertens"},{"key":"10.1016\/j.mehy.2013.01.018_b0285","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4088\/JCP.v67n0704","article-title":"Associations between bipolar disorder and metabolic syndrome: a review","volume":"67","author":"Taylor","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2013.01.018_b0290","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.05.030","article-title":"Modal subcomponents of metabolic syndrome in patients with bipolar disorder","volume":"106","author":"Cardenas","year":"2008","journal-title":"J Affect Disord"},{"key":"10.1016\/j.mehy.2013.01.018_b0295","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jad.2007.06.002","article-title":"The prevalence of metabolic syndrome in patients with bipolar disorder","volume":"106","author":"Garcia-Portilla","year":"2008","journal-title":"J Affect Disord"},{"key":"10.1016\/j.mehy.2013.01.018_b0300","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/PSY.0b013e3182037315","article-title":"Psychological distress predicts the development of the metabolic syndrome: a prospective population-based study","volume":"73","author":"Puustinen","year":"2011","journal-title":"Psychosom Med"},{"key":"10.1016\/j.mehy.2013.01.018_b0305","first-page":"169","article-title":"Metabolic syndrome, somatic and psychiatric comorbidity in war veterans with post-traumatic stress disorder: preliminary findings","volume":"18","author":"Jakovljevic","year":"2006","journal-title":"Psychiatr Danub"},{"key":"10.1016\/j.mehy.2013.01.018_b0310","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/13607861003713299","article-title":"Psychosocial factors and metabolic parameters: is there any association in elderly people? The Massa Lombarda Project","volume":"14","author":"Bove","year":"2010","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.mehy.2013.01.018_b0315","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1161\/01.CIR.0000038364.26310.BD","article-title":"Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study","volume":"106","author":"Brunner","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2013.01.018_b0320","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/meta.2001.19502","article-title":"Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese","volume":"50","author":"Lee","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2013.01.018_b0325","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00125-005-1798-z","article-title":"Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome","volume":"48","author":"Grassi","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.mehy.2013.01.018_b0330","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1177\/0961203309359781","article-title":"Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics","volume":"19","author":"Telles","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.mehy.2013.01.018_b0335","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/03009740903046668","article-title":"Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus","volume":"39","author":"Mok","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.mehy.2013.01.018_b0340","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2008.06.035","article-title":"Age-related macular degeneration and complement activation-related diseases: a population-based case-control study","volume":"115","author":"Nitsch","year":"2008","journal-title":"Ophthalmology"},{"issue":"Suppl. 4","key":"10.1016\/j.mehy.2013.01.018_b0410","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/rheumatology\/kel315","article-title":"Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases","volume":"45","author":"Seferovic","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.mehy.2013.01.018_b0350","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ahj.2010.02.005","article-title":"Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study","volume":"159","author":"Chamberlain","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.mehy.2013.01.018_b0355","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3899\/jrheum.100572","article-title":"Cortisol during the day in patients with systemic lupus erythematosus or primary Sjogren\u2019s syndrome","volume":"38","author":"van der Goes","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.mehy.2013.01.018_b0360","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.2005.038059","article-title":"Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems","volume":"65","author":"Harle","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mehy.2013.01.018_b0365","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1474-8665.2009.00442.x","article-title":"Is elevated noradrenaline an aetiological factor in a number of diseases?","volume":"29","author":"Fitzgerald","year":"2009","journal-title":"Auton Autacoid Pharmacol"},{"key":"10.1016\/j.mehy.2013.01.018_b0370","first-page":"1","article-title":"Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer","volume":"2","author":"Fitzgerald","year":"2010","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.mehy.2013.01.018_b0375","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/CLEP.S33695","article-title":"Beta blockers, norepinephrine, and cancer: an epidemiological view point","volume":"4","author":"Fitzgerald","year":"2012","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.mehy.2013.01.018_b0380","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.seizure.2010.04.011","article-title":"Is elevated norepinephrine an etiological factor in some cases of epilepsy?","volume":"19","author":"Fitzgerald","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.mehy.2013.01.018_b0385","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/156720510792231775","article-title":"Is elevated norepinephrine an etiological factor in some cases of Alzheimer\u2019s disease?","volume":"7","author":"Fitzgerald","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.mehy.2013.01.018_b0390","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-2011-101908","article-title":"Age-related macular degeneration (AMD): alzheimer\u2019s disease in the eye?","volume":"24","author":"Kaarniranta","year":"2011","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.mehy.2013.01.018_b0395","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archophthalmol.2010.355","article-title":"Diabetes mellitus and early age-related macular degeneration","volume":"129","author":"Choi","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.mehy.2013.01.018_b0400","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000121423","article-title":"Clinical description of seizures in patients with systemic lupus erythematosus","volume":"59","author":"Gonzalez-Duarte","year":"2008","journal-title":"Eur Neurol"},{"key":"10.1016\/j.mehy.2013.01.018_b0405","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.ophtha.2010.03.003","article-title":"Comparison of comorbid conditions between open-angle glaucoma patients and a control cohort: a case-control study","volume":"117","author":"Lin","year":"2010","journal-title":"Ophthalmology"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713000418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713000418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T12:25:09Z","timestamp":1562675109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987713000418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0306987713000418"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2013.01.018","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}